InvestorsHub Logo
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

Re: None

Tuesday, 01/03/2017 11:36:46 PM

Tuesday, January 03, 2017 11:36:46 PM

Post# of 866
MRK & NLNK ebola vax inventor now Chairman of tiny GOVX.


Looking likely that MRK or NLNK will buy out this tiny company.

Link:
https://finance.yahoo.com/news/geovax-announces-formation-scientific-advisory-140000691.html


NOTE: The person leading the development with Merck & NLNK is now a Director Of GeoVax. That is big.

"Thomas P. Monath, MD, (Chairman). Dr. Monath currently serves as Chief Scientific Officer and Chief Operating Officer of BioProtection Systems, a subsidiary of NewLink Genetics Corporation, where he is leading the development of an Ebola virus vaccine in partnership with Merck

NOTE 2: GeoVax has an AIDS vaccine that has been 100% effective in human trials. Another round of vaccinations starts this month.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News